alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UNPUBLISHED

UNITED STATES COURT OF APPEALS 

FOR THE FOURTH CIRCUIT 

No. 08-1832

OUSSENE LITTY AGBERE, 

 Petitioner, 

 v. 

ERIC H. HOLDER, JR., Attorney General, 

 Respondent. 

On Petition for Review of an Order of the Board of Immigration 

Appeals.

Submitted: March 31, 2009 Decided: April 10, 2009 

Before MICHAEL, GREGORY, and AGEE, Circuit Judges. 

Petition denied by unpublished per curiam opinion. 

Kell Enow, ENOW & PATCHA, Silver Spring, Maryland, for 

Petitioner. Michael F. Hertz, Acting Assistant Attorney 

General, Carol Federighi, Senior Litigation Counsel, Rebecca 

Hoffberg, UNITED STATES DEPARTMENT OF JUSTICE, Washington, D.C., 

for Respondent.

Unpublished opinions are not binding precedent in this circuit. 
2 

PER CURIAM: 

 Oussene Litty Agbere, a native and citizen of Togo, 

petitions for review of an order of the Board of Immigration 

Appeals affirming the Immigration Judge’s denial of his 

applications for relief from removal. 

 Agbere challenges the determination that he failed to 

establish eligibility for asylum. To obtain reversal of a 

determination denying eligibility for relief, an alien “must 

show that the evidence he presented was so compelling that no 

reasonable factfinder could fail to find the requisite fear of 

persecution.” INS v. Elias-Zacarias, 502 U.S. 478, 483-84 

(1992). We have reviewed the evidence of record and conclude 

that Agbere fails to show that the evidence compels a contrary 

result. Having failed to qualify for asylum, Agbere cannot meet 

the more stringent standard for withholding of removal. Chen v. 

INS, 195 F.3d 198, 205 (4th Cir. 1999); INS v. Cardoza-Fonseca, 

480 U.S. 421, 430 (1987). 

 Accordingly, we deny the petition for review. We 

dispense with oral argument because the facts and legal 

contentions are adequately presented in the materials before the 

court and argument would not aid the decisional process. 

PETITION DENIED
§ 345.32 Hiring. ( a ) Inmate workers are ordinarily hired through waiting lists. Except as noted in § 345.33, inmates are to be placed on the waiting lists in order of receipt of applications for work with Industries, and are to be hired in the same sequence.
( b ) Waiting lists are to be maintained and kept available for scrutiny by auditors and other staff with a need to know. SOI's are encouraged to maintain a waiting list for each FPI factory.
#### § 30.2 What definitions apply to these regulations?

*Department* means the U.S. Department of Justice.

*Order* means Executive Order 12372, issued July 14, 1982, and amended April 8, 1983 and titled “Intergovernmental Review of Federal Programs.”

*Attorney General* means the Attorney General or an official or employee of the Department acting for the Attorney General under a delegation of authority.

*State* means any of the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Commonwealth of the Northern Mariana Islands, Guam, American Samoa, the U.S. Virgin Islands, or the Trust Territory of the Pacific Islands.
State of California

AIR RESOURCES BOARD

ERRATA

STAFF REPORT: INITIAL STATEMENT OF REASONS

PROPOSED REGULATION TO REDUCE GREENHOUSE GAS EMISSIONS FROM

HEAVY-DUTY VEHICLES

Public Hearing Date: December 11, 2008

Date of Initial Statement of Reasons: October 24, 2008

Errata Rel ease Date: November 25, 2008

PLEASE BE ADVISED that this errata corrects an error in an appendix to the Initial

Statement of Reasons fo r the Proposed Regulation to Reduce Greenhouse Gas Emissions from Heavy-Duty Vehicles, dated October 24, 2008. This correction updates the material made available and posted to the Air Resources Board (ARB) rulemaking website on October 24, 2008.

Change to Appendix E of Staff Report

On page E-4 of Appendix E: Fleet Summaries , under the subheading of “Other devices have tried/tested in the past,” ARB has det ermined that the follo wing statement is

inaccurate and is therefore removi ng it from the Staff Report:

• “ Strakes on side of trailer

– did not find fuel economy improvement (in fact,

saw a 1% increase in fuel consumption with them)”

The balance of the Staff Report and append ices remains the same as released on October 24, 2008.

The complete text of the notice and the Init ial Statement of Reas ons are available on the ARB Internet site for this rulemaking at http://www.arb.ca.gov/r egact/2008/ghghdv08/ghghdv08.htm2 Any questions regarding these corrections should be directed to Lori Andreoni, Manager, Board Administration & Regulatory Coordination Un it, at (916) 322-4011, or Trini Balcazar, Regulations Coordinator, at (916) 445-9564.

For individuals with sensory disabilities, this document and other related material can be made available in Braille, large print, audioca ssette, or computer disk. For assistance, please contact ARB's Reasonable Accomm odations/Disability Coordinator at 916-323-4916 by voice, or through the California Relay Services at 711, to place your request for disability services, or go to http://www.arb.ca. gov/html/ada/ada.htm

.

CALIFORNIA AIR RESOURCES BOARD

/s/

James N. Goldstene

Executive Officer Date: November 17, 2008
Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Robert A. Kaiser, certify that:

1. I have reviewed this annual report on Form 10-K of CellStar Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report; and

3. Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.



/s/ Robert A. KaiserRobert A. Kaiser, Chief Executive Officer


Date: March 30, 2006
### §1423a. Prohibitions

#### (a) In general

It is unlawful for any person who is subject to the jurisdiction of the United States or any person in waters or on lands under the jurisdiction of the United States—

(1) to take any polar bear in violation of the Agreement;

(2) to take any polar bear in violation of the Agreement or any annual taking limit or other restriction on the taking of polar bears that is adopted by the Commission pursuant to the Agreement;

(3) to import, export, possess, transport, sell, receive, acquire, or purchase, exchange, barter, or offer to sell, purchase, exchange, or barter any polar bear, or any part or product of a polar bear, that is taken in violation of paragraph (2);

(4) to import, export, sell, purchase, exchange, barter, or offer to sell, purchase, exchange, or barter, any polar bear gall bile or polar bear gall bladder;

(5) to attempt to commit, solicit another person to commit, or cause to be committed, any offense under this subsection; or

(6) to violate any regulation promulgated by the Secretary to implement any of the prohibitions established in this subsection.

#### (b) Exceptions

For the purpose of forensic testing or any other law enforcement purpose, the Secretary, and Federal law enforcement officials, and any State or local law enforcement official authorized by the Secretary, may import a polar bear or any part or product of a polar bear.

(Pub. L. 92–522, title V, §502, as added Pub. L. 109–479, title IX, §902(a), Jan. 12, 2007, 120 Stat. 3661.)
#### THE PEOPLE OF THE TERRITORY OF GUAM Plaintiff-Appellee v. FRANCISCO C. CAMACHO, Defendant-Appellant

Criminal No. 76-010-A

District Court of Guam Appellate Division

January 24, 1978

Before DUEÑAS, SMITH and WONG, *District Judges*

PER CURIAM

OPINION

The defendant, Francisco C. Camacho, was found guilty on February 4, 1976, of three counts of first degree mur*469der. At trial, defendant admitted that he was responsible for the killings as alleged in the indictment, but claimed that he had lost control of himself and feared that someone had added LSD to his coffee on the night of the killings. At the beginning of trial, the court made the following order: “If there are any persons who have been subpoenaed to testify other than medical witnesses, any persons who are expected to testify, they must wait out in the corridor to be called.” (RT 3:7.) A Dr. Sukow, who was called by the Government in rebuttal, discussed with the Attorney General the testimony given by the defendant. It is claimed that this discussion violated the exclusion order.

There was no violation of the exclusion order for these reasons. First, the medical witness (Dr. Sukow) was excepted from the order by its express terms and we are unable to determine from the record that the order was ever amended. Second, even if medical witnesses had not been excepted, the order did not preclude the attorneys from discussing the testimony which had been given with prospective witnesses. Finally, the trial court did not deem that the defendant was prejudiced by what was done and we are unable in the record to discover that there was any prejudice. Affirmed.
S. 998 

One Hundred Sixteenth Congress 

of the 

United States of America 

AT THE FIRST SESSION 

Begun and held at the City of Washington on Thursday, 

the third day of January, two thousand and nineteen 

An Act 

To amend the Omnibus Crime Control and Safe Streets Act of 1968 to expand 

support for police officer family services, stress reduction, and suicide prevention, 

and for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Supporting and Treating Officers 

In Crisis Act of 2019’’. 

SEC. 2. EXPANDING SUPPORT FOR POLICE OFFICER FAMILY SERVICES, 

STRESS REDUCTION, AND SUICIDE PREVENTION. 

Part W of title I of the Omnibus Crime Control and Safe 

Streets Act of 1968 (34 U.S.C. 10491 et seq.) is amended— 

(1) in the part heading, by striking ‘‘FAMILY SUPPORT’’ 

and inserting ‘‘SUPPORT FOR LAW ENFORCEMENT OFFICERS

AND FAMILIES’’; 

(2) in section 2301 (34 U.S.C. 10491)— 

(A) in paragraph (2), by inserting ‘‘, including any 

research and reports developed under the Law Enforcement 

Mental Health and Wellness Act of 2017 (Public Law 115– 

113; 131 Stat. 2276)’’ after ‘‘interested parties’’; and 

(B) in paragraph (4), by inserting ‘‘, psychological services, suicide prevention,’’ after ‘‘stress reduction’’; 

(3) in section 2302 (34 U.S.C. 10492), by inserting ‘‘and 

mental health services’’ after ‘‘family support services’’; and 

(4) in section 2303 (34 U.S.C. 10493)— 

(A) in subsection (b)— 

(i) in paragraph (1), by inserting ‘‘officers and’’ 

after ‘‘law enforcement’’; and 

(ii) by amending paragraph (4) to read as follows: 

‘‘(4) Evidence-based programs to reduce stress, prevent suicide, and promote mental health.’’; and 

(B) in subsection (c)— 

(i) in paragraph (5), by inserting ‘‘, mental health 

crisis, and suicide prevention’’ after ‘‘family crisis’’; 

(ii) in paragraph (6), by striking ‘‘the human 

immunodeficiency virus’’ and inserting ‘‘infectious disease’’; 

(iii) in paragraph (8), by inserting ‘‘, injured, or 

permanently disabled’’ after ‘‘killed’’; and 

(iv) by striking paragraph (10) and inserting the 

following: 
S. 998—2 

‘‘(10) Specialized training for identifying, reporting, and 

responding to officer mental health crises and suicide. 

‘‘(11) Technical assistance and training to support any or 

all of the services described in paragraphs (1) through (10).’’. 

SEC. 3. REAUTHORIZING GRANT PROGRAMS FOR SUPPORTING LAW 

ENFORCEMENT OFFICERS AND FAMILIES. 

Section 1001(a)(21) of title I of the Omnibus Crime Control 

and Safe Streets Act of 1968 (34 U.S.C. 10261(a)(21)) is amended 

to read as follows: 

‘‘(21) There are authorized to be appropriated to carry out 

part W, $7,500,000 for each of fiscal years 2020 through 2024.’’. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
Pictured is an Latin male super hero washing his hands and with the 

text that says “Do good; Wash your hands!”
#### § 345.50 General.

Title 18 U. S. Code section 4126 authorizes FPI to compensate inmates under rules and regulations promulgated by the Attorney General. It is the policy of FPI to provide compensation to FPI inmate workers through various conditions of pay and benefits, except as otherwise provided in these regulations.
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 744 Referred in House (RFH)]

<DOC>

116th CONGRESS
  1st Session
                                 S. 744

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 20, 2019

               Referred to the Committee on the Judiciary

_______________________________________________________________________

                                 AN ACT

 
  To amend section 175b of title 18, United States Code, to correct a 
                           scrivener's error.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Effective Prosecution of Possession 
of Biological Toxins and Agents Act of 2019''.

SEC. 2. PROHIBITION ON THE POSSESSION OF BIOLOGICAL TOXINS AND AGENTS.

    Section 175b of title 18, United States Code, is amended--
            (1) in subsection (a)--
                    (A) by striking ``(a)(1) No restricted'' and all 
                that follows through the end of paragraph (1) and 
                inserting the following:
    ``(a) Offense.--
            ``(1) In general.--It shall be unlawful for a restricted 
        person to--
                    ``(A) ship, transport, or possess in or affecting 
                interstate or foreign commerce any biological agent or 
                toxin described in paragraph (2); or
                    ``(B) receive any biological agent or toxin 
                described in paragraph (2) that has been shipped or 
                transported in interstate or foreign commerce.
            ``(2) Agents and toxins covered.--A biological agent or 
        toxin described in this paragraph is a biological agent or 
        toxin that--
                    ``(A) is listed as a non-overlap or overlap select 
                biological agent or toxin under part 73 of title 42, 
                Code of Federal Regulations, pursuant to section 351A 
                of the Public Health Service Act (42 U.S.C. 262a); and
                    ``(B) is not excluded or exempted under part 73 of 
                title 42, Code of Federal Regulations.''; and
                    (B) by striking ``(2) Whoever'' and inserting ``(3) 
                Penalty.--Whoever'' and adjusting the margin 
                accordingly; and
            (2) in subsection (d), in the matter preceding paragraph 
        (1), by inserting ``Definitions.--'' before ``In this 
        section:''.

            Passed the Senate May 16, 2019.

            Attest:

                                                JULIE E. ADAMS,

                                                             Secretary.
```
### §80b–4a. Prevention of misuse of nonpublic information

Every investment adviser subject to section 80b–4 of this title shall establish, maintain, and enforce written policies and procedures reasonably designed, taking into consideration the nature of such investment adviser's business, to prevent the misuse in violation of this chapter or the Securities Exchange Act of 1934 [15 U.S.C. 78a et seq.], or the rules or regulations thereunder, of material, nonpublic information by such investment adviser or any person associated with such investment adviser. The Commission, as it deems necessary or appropriate in the public interest or for the protection of investors, shall adopt rules or regulations to require specific policies or procedures reasonably designed to prevent misuse in violation of this chapter or the Securities Exchange Act of 1934 (or the rules or regulations thereunder) of material, nonpublic information.

(Aug. 22, 1940, ch. 686, title II, §204A, as added Pub. L. 100–704, §3(b)(2), Nov. 19, 1988, 102 Stat. 4680.)

#### **Editorial Notes**

#### References in Text

The Securities Exchange Act of 1934, referred to in text, is act June 6, 1934, ch. 404, 48 Stat. 881, which is classified principally to chapter 2B (§78a et seq.) of this title. For complete classification of this Act to the Code, see section 78a of this title and Tables.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Section not applicable to actions occurring before Nov. 19, 1988, see section 9 of Pub. L. 100–704 set out as an Effective Date of 1988 Amendment note under section 78o of this title.
#### Jordan *v.*Strange.

April 16, 1910.

Action for breach of warranty. Before Judge Littlejohn. Schley superior court.

May *22,*1909.

*Hart & Taylor*and *Shipp & Sheppard,*for plaintiff in error.

*Charles R. McCrory,*contra.

Lumpkin, J.

The verdict in this case was authorized by the evidence. No error was assigned except the overruling of the motion for a new trial, based on the .general grounds that the verdict was contrary to law and evidence, and to the weight of the evidence, and was without evidence to support it. There was no error in overruling the motion.

*Judgment affirmed.*

*All the Justices concur.*
MEMORANDUM

Subject: Summary of Stakeholder Meeting including a Discussion on Ozone NAAQS

Proposal

From: Scott Jenkins

To: Docket EPA-HQ-OAR-2008-0699

Date: February 27, 2015

On February 27, 2015, staff members from the U.S. EPA, Office of Air Quality Planning and

Standards, met with industry representatives. The EPA staff fielded general questions pertaining

to the agency’s November 25, 2015, proposed revisions to the National Ambient Air Quality 

Standards for Ozone.

There were no meeting materials.

The attendees were as follows:

U.S. Environmental Protection Agency

Scott Jenkins

Kimber Scavo

Michael Ling

Carla Oldham

Heather Simon

Butch Stackhouse

Lynne Dail

Nicole Hagen

The industry representatives were:

Helene Hardy Pierce – GAF

Gregory Johnson – Sherwin-Williams

John Ferraro – Roof Coatings Manufacturers Association

Stacey-Anne Taylor – The Henry Company
<PAGE>

                                                                EXHIBIT 23.1

                         CONSENT OF INDEPENDENT ACCOUNTANTS

     We hereby consent to the incorporation by reference in the Registration
Statements on Forms S-8 (File Nos. 333-12411 and 333-93201) and the
Registration Statements of Forms S-3 (File Nos. 333-81457 and 333-36798), of
Cambridge Heart, Inc. of our report dated February 2, 2001 relating to the
financial statements of Cambridge Heart, Inc., which appears in the Annual
Report on Form 10-K for the year ended December 31, 2000.




PricewaterhouseCoopers LLP

Boston, Massachusetts
March 23, 2001
#### Futch, administratrix, *v.*James.

June 24, 1910.

Complaint for land. Before Judge Hammond. Richmond superior court.

April 28, 1909.

*B. L. Strange*and *B. B. McCowen,*for plaintiff.

*Lamar & Callaway,*for defendant.

Lumpkin, J.

Under the pleadings and evidence in this ease, there was no

error in admitting the evidence complained of and in directing a verdict for the defendant. *Judgment affirmed.*

*All the Justices concur.*
§ 115.222 Policies to ensure referrals of allegations for investigations. ( a ) The agency shall ensure that an administrative or criminal investigation is completed for all allegations of sexual abuse and sexual harassment.
( b ) The agency shall have in place a policy to ensure that allegations of sexual abuse or sexual harassment are referred for investigation to an agency with the legal authority to conduct criminal investigations, unless the allegation does not involve potentially criminal behavior. The agency shall publish such policy on its Web site or, if it does not have one, make the policy available through other means. The agency shall document all such referrals.
( c ) If a separate entity is responsible for conducting criminal investigations, such publication shall describe the responsibilities of both the agency and the investigating entity.
( d ) Any State entity responsible for conducting administrative or criminal investigations of sexual abuse or sexual harassment in community confinement facilities shall have in place a policy governing the conduct of such investigations.
( e ) Any Department of Justice component responsible for conducting administrative or criminal investigations of sexual abuse or sexual harassment in community confinement facilities shall have in place a policy governing the conduct of such investigations.
EXHIBIT 32.1
 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    The Quarterly Report on Form 10-Q for the quarterly period ended September 26,
2009 of the Company, as filed with the Securities and Exchange Commission on the date
hereof (the Report), fully complies with the requirements of section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and2.
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
  /s/ Robert W. HumphreysRobert W. HumphreysChairman, Chief Executive Officer,
President and Director  21
Exhibit
32.1





CERTIFICATION
PURSUANT


TO
18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION 
906 OF THE SARBANES-OXLEY ACT OF 2002





The
undersigned Chief Executive Officer and Chief Science Officer of Progenics
Pharmaceuticals, Inc. (the “Company”) does hereby certify as
follows:





This
annual report on Form 10-K of the Company for the period ended December 31,
2008 and filed with the Securities and Exchange Commission on the date hereof
(the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 and the information contained in the Report
fairly presents, in all material respects, the financial condition and results
of operations of the Company.





/s/
      Paul J. Maddon, M.D., Ph.D.Date:
      March 13, 2009
              Paul
      J. Maddon, M.D., Ph.D.
                Chief
      Executive Officer and Chief
                Science
      Officer (Principal Executive
Officer)








A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to Progenics Pharmaceuticals, Inc. and
will be retained by Progenics Pharmaceuticals, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.